title: Digestive disease week 2011: highlights of clinical and preclinical research on Barrett's esophagus and associated esophageal adenocarcinoma.
abstract: Clinicians and basic researchers worldwide convened at the annual Digestive Disease Week where the latest research in the field of gastroenterology and hepatology is presented. In this report, the highlights of the convention on the field of Barrett's esophagus (BE) and associated esophageal adenocarcinoma (EAC) are summarized. New clinical and preclinical developments in etiology, diagnosis, surveillance, and prevention and therapy of BE and EAC in respect to current knowledge are reflected. We also discuss the relevance and impact of these findings on the future of BE and EAC research.
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. a.vandewinkel@erasmusmc.nl
authors.forename: A
authors.initials: A
authors.lastname: van de Winkel
authors.forename: R
authors.initials: R
authors.lastname: Massl
authors.forename: E J
authors.initials: EJ
authors.lastname: Kuipers
authors.forename: L J W
authors.initials: LJ
authors.lastname: van der Laan
authors.forename: M P
authors.initials: MP
authors.lastname: Peppelenbosch
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D001471:Barrett Esophagus / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D015415:Biomarkers / Q000378:metabolism; D001706:Biopsy; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D016629:Esophagectomy; D004945:Esophagoscopy; D004947:Esophagus / Q000473:pathology; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D005765:Gastrointestinal Agents